FDA Inspection 1115610 — The University of Kansas Health System
The FDA completed an inspection of The University of Kansas Health System on December 23, 2019 in Kansas City, KS. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- December 23, 2019
- Fiscal Year
- 2020
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Kansas City, KS (United States)